Meta analysis of epidermal growth factor 61 A/G polymorphism and sus-ceptibility of gastric cancer

Mingzhu WANG,Shiyun TAN,Fang GUO,Yongxiang SHU

2015-01-01

Abstract:Objective To evaluate the relevance of epidermal growth factor (EGF) 61 A/G polymorphism and suscepti-bility of gastric cancer. Methods The database of PubMed, Medline, EMbase, CBM, CNKI, Wanfang and VIP pub-lished from constructing database to January 1, 2015 were searched, so as to collect case-control study about EGF61 A/G polymorphism and susceptibility of gastric cancer. Pooled odds ratios (OR) with 95%confidence intervals (95%CI) were calculated by the RevMan 5.2 and Stata 12.0 software. Results Six controlled clinical trials (1502 cases and 2762 con-trols) were enrolled. Meta-analysis showed that there were significant differences of relevance between EGF61 A/G polymorphism and susceptibility of gastric cancer in the three genetic models (dominant model: OR = 1.31, 95%CI:1.06-1.61; recessive model: OR =1.27, 95%CI:1.01-1.60; GG vs AA: OR = 1.39, 95%CI: 1.10-1.76), however, there was no significant difference between AG model and AA model (OR =1.23, 95%CI: 0.98-1.54). The subgroup analysis by ethnicity showed that EGF61 A/G polymorphism could increase the risk of gastric cancer of Asian population (dom-inant model: OR = 1.47, 95%CI: 1.13-1.91; recessive model: OR = 1.37, 95%CI: 1.16-1.60; GG v s AA: OR = 1.66, 95%CI: 1.27-2.17). However, it had no relevance with the risk gastric cancer of the white population. Conclusion Based on the current research results, EGF61 A/G polymorphism is associated with the susceptibility of gastric cancer, and EGF61 A/G polymorphism can increase the risk of gastric cancer in Asian population.